74399-92-1

Basic information

• Product Name: (2Z)-3-(4-methylphenyl)-2-{[(naphthalen-2-ylamino)methyl]imino}-1,3-thiazolidin-4-one
• CAS NO: 74399-92-1
• Molecular Formula: C₂₁H₁₉N₃OS
• Molecular Weight: 361.4601
• Mol File: 74399-92-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 577.166°C at 760 mmHg
• Flash Point: 302.859°C
• Density: 1.257g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.672
• CAS DataBase Reference: (2Z)-3-(4-methylphenyl)-2-{[(naphthalen-2-ylamino)methyl]imino}-1,3-thiazolidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2Z)-3-(4-methylphenyl)-2-{[(naphthalen-2-ylamino)methyl]imino}-1,3-thiazolidin-4-one(74399-92-1)
• EPA Substance Registry System: (2Z)-3-(4-methylphenyl)-2-{[(naphthalen-2-ylamino)methyl]imino}-1,3-thiazolidin-4-one(74399-92-1)

Safety Data

• Hazardous Substances Data: 74399-92-1(Hazardous Substances Data)

Usage

Description

(2Z)-3-(4-methylphenyl)-2-[(naphthalen-2-ylamino)methyl]imino-1,3-thiazolidin-4-one, also known as MPTI, is a thiazolidinone derivative with potential anti-inflammatory and anti-cancer properties. It has been studied for its ability to inhibit the activity of certain enzymes involved in inflammation and carcinogenesis. MPTI has shown promising results in preclinical studies as a potential therapeutic agent for various inflammatory and cancer-related conditions. Its unique chemical structure and mode of action make it an interesting target for further research and development as a potential drug candidate.

Uses

Used in Pharmaceutical Industry:
MPTI is used as a potential therapeutic agent for various inflammatory and cancer-related conditions due to its ability to inhibit the activity of certain enzymes involved in inflammation and carcinogenesis.
Used in Research and Development:
MPTI is used as a potential drug candidate for further research and development, given its unique chemical structure and mode of action.